Tokyo Tape
Sign in
← Medical Ikkou Group

Quarterly report · Q3

3353.TEDINET S100PYK8
Period2022-03-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥25.4bn2022-03-01 → 2022-11-30Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28Cons.Net sales (5-year summary)
Revenue¥25.2bn2021-03-01 → 2021-11-30Cons.Net sales
Operating income¥706m2022-03-01 → 2022-11-30Cons.Operating income
Operating income¥1.0bn2021-03-01 → 2021-11-30Cons.Operating income
Ordinary income¥888m2022-03-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.1bn2021-03-01 → 2021-11-30Cons.Ordinary income
Profit before tax¥998m2022-03-01 → 2022-11-30Cons.Income before income taxes
Profit before tax¥1.2bn2021-03-01 → 2021-11-30Cons.Income before income taxes
Net income (owners)¥597m2022-03-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥670m2021-03-01 → 2021-11-30Cons.Profit loss attributable to owners of parent
Net income¥623m2022-03-01 → 2022-11-30Cons.Profit loss
Net income¥694m2021-03-01 → 2021-11-30Cons.Profit loss
Total assets¥28.0bnat 2022-11-30Cons.Assets
Total assets¥29.1bnat 2022-02-28Cons.Assets
Total assets¥29.6bnat 2021-11-30Cons.Total assets (5-year summary)
Total liabilities¥15.6bnat 2022-11-30Cons.Liabilities
Total liabilities¥17.2bnat 2022-02-28Cons.Liabilities
Net assets / equity¥12.4bnat 2022-11-30Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28Cons.Net assets
Net assets / equity¥11.7bnat 2021-11-30Cons.Net assets (5-year summary)
Cash and deposits¥6.6bnat 2022-11-30Cons.Cash and deposits
Cash and deposits¥8.0bnat 2022-02-28Cons.Cash and deposits
EPS (basic)¥1592022-03-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.342022-09-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥178.382021-03-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.152021-09-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio42.3%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio37.7%at 2021-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-11-30−¥744m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-11-30−¥744m
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-11-30−¥557m
jpcrp040300-q3r_E03443-000Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2022-11-30¥17.3bn
jpcrp040300-q3r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2022-11-30¥17.3bn
jpcrp040300-q3r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2022-11-30¥1.1bn
jpcrp040300-q3r_E03443-000Health Carereportable segmentrevenue2022-03-01 → 2022-11-30¥5.8bn
jpcrp040300-q3r_E03443-000Health Carereportable segmentrevenue external2022-03-01 → 2022-11-30¥5.8bn
jpcrp040300-q3r_E03443-000Health Carereportable segmentrevenue intersegment2022-03-01 → 2022-11-30¥450,000
jpcrp040300-q3r_E03443-000Health Carereportable segmentsegment profit2022-03-01 → 2022-11-30¥35m
jpcrp040300-q3r_E03443-000Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2022-11-30¥2.9bn
jpcrp040300-q3r_E03443-000Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2022-11-30¥2.2bn
jpcrp040300-q3r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2022-11-30¥742m
jpcrp040300-q3r_E03443-000Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2022-11-30¥29m
jpcrp040300-q3r_E03443-000Real Estatereportable segmentrevenue2022-03-01 → 2022-11-30¥142m
jpcrp040300-q3r_E03443-000Real Estatereportable segmentrevenue external2022-03-01 → 2022-11-30¥140m
jpcrp040300-q3r_E03443-000Real Estatereportable segmentrevenue intersegment2022-03-01 → 2022-11-30¥1m
jpcrp040300-q3r_E03443-000Real Estatereportable segmentsegment profit2022-03-01 → 2022-11-30¥92m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-11-30¥26.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-11-30¥25.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-11-30¥744m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-11-30¥1.3bn
Reconciling Itemsreconcilingrevenue2021-03-01 → 2021-11-30−¥808m
Reconciling Itemsreconcilingrevenue intersegment2021-03-01 → 2021-11-30−¥808m
Reconciling Itemsreconcilingsegment profit2021-03-01 → 2021-11-30−¥518m
jpcrp040300-q3r_E03443-000Dispensing Pharmacyreportable segmentrevenue2021-03-01 → 2021-11-30¥17.0bn
jpcrp040300-q3r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2021-03-01 → 2021-11-30¥17.0bn
jpcrp040300-q3r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2021-03-01 → 2021-11-30¥1.1bn
jpcrp040300-q3r_E03443-000Health Carereportable segmentrevenue2021-03-01 → 2021-11-30¥5.9bn
jpcrp040300-q3r_E03443-000Health Carereportable segmentrevenue external2021-03-01 → 2021-11-30¥5.9bn
jpcrp040300-q3r_E03443-000Health Carereportable segmentrevenue intersegment2021-03-01 → 2021-11-30¥450,000
jpcrp040300-q3r_E03443-000Health Carereportable segmentsegment profit2021-03-01 → 2021-11-30¥225m
jpcrp040300-q3r_E03443-000Medical Products Wholesalereportable segmentrevenue2021-03-01 → 2021-11-30¥2.9bn
jpcrp040300-q3r_E03443-000Medical Products Wholesalereportable segmentrevenue external2021-03-01 → 2021-11-30¥2.1bn
jpcrp040300-q3r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2021-03-01 → 2021-11-30¥806m
jpcrp040300-q3r_E03443-000Medical Products Wholesalereportable segmentsegment profit2021-03-01 → 2021-11-30¥72m
jpcrp040300-q3r_E03443-000Real Estatereportable segmentrevenue2021-03-01 → 2021-11-30¥175m
jpcrp040300-q3r_E03443-000Real Estatereportable segmentrevenue external2021-03-01 → 2021-11-30¥174m
jpcrp040300-q3r_E03443-000Real Estatereportable segmentrevenue intersegment2021-03-01 → 2021-11-30¥1m
jpcrp040300-q3r_E03443-000Real Estatereportable segmentsegment profit2021-03-01 → 2021-11-30¥98m
Total Of Reportable Segments And Otherssegment totalrevenue2021-03-01 → 2021-11-30¥26.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-03-01 → 2021-11-30¥25.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-03-01 → 2021-11-30¥808m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-03-01 → 2021-11-30¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 366
ItemContextValueUnit
Selling general and administrative expensesPrior1YTDDuration1735509000JPY
Selling general and administrative expensesCurrentYTDDuration1719849000JPY
Operating incomePrior1YTDDuration1008560000JPY
Operating incomeCurrentYTDDuration705553000JPY
Interest income noiPrior1YTDDuration1062000JPY
Interest income noiCurrentYTDDuration901000JPY
Dividends income noiPrior1YTDDuration17545000JPY
Dividends income noiCurrentYTDDuration20729000JPY
Subsidy income noi bountyPrior1YTDDuration47498000JPY
Subsidy income noi bountyCurrentYTDDuration124283000JPY
Gain on reversal of advance received noiPrior1YTDDuration－JPY
Gain on reversal of advance received noiCurrentYTDDuration48528000JPY
Penalty income noiPrior1YTDDuration24000000JPY
Penalty income noiCurrentYTDDuration－JPY
Other noiPrior1YTDDuration28336000JPY
Other noiCurrentYTDDuration30877000JPY
Non operating incomePrior1YTDDuration118442000JPY
Non operating incomeCurrentYTDDuration225320000JPY
Interest expenses noePrior1YTDDuration44352000JPY
Interest expenses noeCurrentYTDDuration39152000JPY
Other noePrior1YTDDuration1869000JPY
Other noeCurrentYTDDuration3612000JPY
Non operating expensesPrior1YTDDuration46222000JPY
Non operating expensesCurrentYTDDuration42764000JPY
Ordinary incomePrior1YTDDuration1080780000JPY
Ordinary incomeCurrentYTDDuration888109000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration1018000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration20774000JPY
Gain on sales of investment securities eiPrior1YTDDuration115311000JPY
Gain on sales of investment securities eiCurrentYTDDuration23065000JPY
Gain on transfer of business eiPrior1YTDDuration－JPY
Gain on transfer of business eiCurrentYTDDuration69000000JPY
Extraordinary incomePrior1YTDDuration116329000JPY
Extraordinary incomeCurrentYTDDuration112840000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration1109000JPY
Loss on sales of noncurrent assets elCurrentYTDDuration－JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration854000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration177000JPY
Loss on sales of investment securities elPrior1YTDDuration－JPY
Loss on sales of investment securities elCurrentYTDDuration618000JPY
Loss on valuation of investment securities elPrior1YTDDuration10000000JPY
Loss on valuation of investment securities elCurrentYTDDuration－JPY
Loss on cancellation of leasehold contracts elPrior1YTDDuration4352000JPY
Loss on cancellation of leasehold contracts elCurrentYTDDuration2584000JPY
Extraordinary lossPrior1YTDDuration16315000JPY
Extraordinary lossCurrentYTDDuration3380000JPY
Income before income taxesPrior1YTDDuration1180794000JPY
Income before income taxesCurrentYTDDuration997569000JPY
Income taxes currentPrior1YTDDuration559400000JPY
Income taxes currentCurrentYTDDuration420840000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-02-28pass
balance sheet identityconsolidated 2022-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-03-01/2021-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-11-30pass
statement vs summary · revenueconsolidated 2021-03-01/2021-11-30pass
statement vs summary · revenueconsolidated 2022-03-01/2022-11-30pass
statement vs summary · total assetsconsolidated 2022-02-28pass
statement vs summary · total assetsconsolidated 2022-11-30pass